Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals Limited has submitted a disclosure to the NSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Regulation 30 requires listed companies to promptly inform the exchange about material events or developments that could affect investors' decisions. The headline itself does not specify the nature of the event being disclosed, and the detailed contents of the intimation are not available in the provided text. Shareholders and investors would need to refer to the full filing on the NSE/BSE corporate announcements portal for the specifics of the disclosure.
The specific impact on shareholders or the stock price cannot be assessed without knowing the nature of the material event disclosed. Investors should review the full filing to understand the details and implications.